Why might three different chemotherapy agents be given in combination?

• A. To shorten the overall treatment time
• B. To target different processes outside the cell cycle
• C. To reduce the risk of drug interactions
• D. To target different areas of the cell cycle

Answer: (D)

Combining three chemotherapy agents is most effective when they cover different stages of the cell cycle. Tumor cells don’t all progress through the cycle at the same rate, and some drugs work best only at specific phases (for example, certain agents act mainly during DNA synthesis while others disrupt mitosis), while others can damage cells regardless of phase. Using a combination that targets multiple phases means more cancer cells are vulnerable at any given time, increasing chances of killing more cells overall and helping to prevent resistance that can arise if only one phase is targeted. Additionally, this approach can allow using lower doses of each drug, potentially reducing specific toxicities.

This is why targeting different areas of the cell cycle is the best way to describe the rationale for giving three agents together. Shortening treatment time is not the primary goal, drug interactions are a consideration but not the motivating idea, and focusing on processes outside the cell cycle isn’t the main strategy since the strength lies in hitting multiple cell-cycle phases.